Lazard Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $424K | Buy |
+116,485
| New | +$424K | ﹤0.01% | 1540 |
|
|
2024
Q2 | – | Sell |
-43,545
| Closed | -$79K | – | 2212 |
|
|
2024
Q1 | $79K | Buy |
+43,545
| New | +$79K | ﹤0.01% | 1605 |
|
|
2020
Q3 | – | Sell |
-5,972
| Closed | -$81K | – | 1598 |
|
|
2020
Q2 | $81K | Buy |
+5,972
| New | +$81K | ﹤0.01% | 1068 |
|
|
2019
Q4 | – | Sell |
-2,645
| Closed | -$10K | – | 1519 |
|
|
2019
Q3 | $10K | Buy |
+2,645
| New | +$10K | ﹤0.01% | 1302 |
|